Stevanato Group S.p.A.

Listed Company
STVNCIK 0001849853NYSELarge AcceleratedSurgical & Medical Instruments & ApparatusIT
Period
FY 2025
Revenue
Net Income
$139.83M
Total Assets
$2.54B
Equity
Shares Out
302.84M
Op. Cash Flow

Business

Stevanato Group S.p.A. is a global provider of integrated drug containment, drug delivery, diagnostic and engineering solutions for the pharmaceutical, biotechnology and life sciences industries. It offers pharmaceutical-grade primary packaging (pre-fillable syringes, vials, cartridges, ampoules), drug delivery devices (pen injectors, auto-injectors, wearable injectors), IVD consumables and analytical/regulatory services, plus assembly, inspection and packaging machinery and after‑sales support. The company operates two reporting segments — Biopharmaceutical and Diagnostic Solutions and Engineering — and sells B2B across EMEA, the U.K., Asia (notably China) and the Americas via direct sales and selected distributors.

Summary from filing dated 2025-03-06

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue
Net income$139.83M
Total assets$2.54B
Total liabilities$1.06B
Stockholders' equity
Operating cash flow

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro